Di­a­comit listed

Pharmacy Daily - - News -

CHIESI Aus­tralia’s Di­a­comit (stiripen­tol) has be­com­ing the first new treat­ment for seizures as­so­ci­ated with Dravet syn­drome to be listed on the Phar­ma­ceu­ti­cal Ben­e­fits Scheme (PBS) in more than a decade.

The drug was ap­proved by the Ther­a­peu­tic Goods Ad­min­is­tra­tion last year, and be­came avail­able through the PBS on 01 Aug.

The list­ing is also the first for the newly formed Chiesi Aus­tralia.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.